These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7191283)

  • 1. Models and methods for the assessment of cumulation of drug effects.
    Brock N; Schneider B
    Arzneimittelforschung; 1980; 30(7):1034-40. PubMed ID: 7191283
    [No Abstract]   [Full Text] [Related]  

  • 2. [Individualized drug therapy].
    Aarbakke J
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2794-5. PubMed ID: 11107927
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspects of pharmacokinetics and biopharmaceutics in relation to drug activity.
    Wagner JG
    Am J Pharm Sci Support Public Health; 1969; 141(1):5-20. PubMed ID: 5776857
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug receptor theory as a basis of the action of drugs. Possibilities and limitations].
    van Rossum JM
    Arzneimittelforschung; 1966 Nov; 16(11):1412-26. PubMed ID: 6015003
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of cyclophosphamide and ifosfamide pharmacology.
    Fleming RA
    Pharmacotherapy; 1997; 17(5 Pt 2):146S-154S. PubMed ID: 9322882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The principles of pharmacology.
    Vajda FJ
    Aust Fam Physician; 1980 Mar; 9(3):134-141. PubMed ID: 7369946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of interaction between drugs and biological systems.
    Segre G
    Farmaco Sci; 1968 Oct; 23(10):907-18. PubMed ID: 5712792
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methodological problems of studying the pharmacology of the kidneys].
    Berkhin EB
    Farmakol Toksikol; 1979; 42(4):339-46. PubMed ID: 383500
    [No Abstract]   [Full Text] [Related]  

  • 9. Analytical pharmacology: the impact of numbers on pharmacology.
    Kenakin T; Christopoulos A
    Trends Pharmacol Sci; 2011 Apr; 32(4):189-96. PubMed ID: 21397341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of receptor regulation during repeated administration of drugs].
    Montastruc JL; Galitzky J; Berlan M; Montastruc P
    Therapie; 1993; 48(5):421-6. PubMed ID: 8146818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology.
    Neubig RR; Spedding M; Kenakin T; Christopoulos A;
    Pharmacol Rev; 2003 Dec; 55(4):597-606. PubMed ID: 14657418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
    Claude JR; Claude N
    Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations.
    Gabrielsson J; Dolgos H; Gillberg PG; Bredberg U; Benthem B; Duker G
    Drug Discov Today; 2009 Apr; 14(7-8):358-72. PubMed ID: 19162219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
    Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
    IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General principles of pharmacology.
    Terézhalmy GT; Gagliardi VB
    Dent Clin North Am; 1994 Oct; 38(4):585-601. PubMed ID: 7805936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Planning for Phase I in clinico-pharmacological research].
    Dudeck J; Höbel W; Valk HU
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1625-8. PubMed ID: 4801608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.